BioInvest
Cicada Innovations Expands to Westmead Health & Innovation District with Investment NSW Support
The incubator will be the first health-focused incubator funded by the NSW government to support pre-revenue health-tech startups in bridging the gap betwe...
August 04, 2023 | News
NAVI Raises $2.4 Million for Breakthrough Medical Device Aiding Critically Ill Newborns
After a successful raise Navi Medical Technologies has closed a $2.4 million round of funding, which included a $700,000 lead in...
August 03, 2023 | News
Indonesia-China Healthcare and Biotech Investment Forum Explores Collaborative Opportunities
The forum was chaired by Mr. Jafar WANG, Co-Chief Investment Officer of Legend Capital, who mentioned Legend Capital's latest "Ecosystem plus" strategy in ...
August 01, 2023 | News
Telix Reports Continued Double-Digit Revenue Growth and Positive Operating Cash Flow
Summary Total revenue up 21% quarter-on-quarter to $120.7M driven by global product sales Positive operating cash flow ($10.8M, an improvemen...
July 20, 2023 | News
Harbour BioMed's 2023 Interim Results: Positive Profit Alert Driven by Innovation
Based on the preliminary review of the Company's unaudited management accounts for the six months ended June 30, 2023, the total revenue is ex...
July 14, 2023 | News
NK:IO Secures £1.6M Innovate UK Grant for Pioneering Cancer Therapy
Grant award of £1.6M supports program of development work with Cell and Gene Therapy Catapult NK:IO’s platform, based on pionee...
July 11, 2023 | News
ENPICOM secures extended financing to continue driving breakthroughs in therapeutic discovery
ENPICOM, an innovative bioinformatics software engineering company, has successfully secured further financial backing from its current investors BOP Capit...
July 07, 2023 | News
Merck Invests €70 Million to Expand Reagent Manufacturing in China
Adds production capacity to further provide customers with highly purified reagents for quality control and testing Major investment at company’s ...
July 04, 2023 | News
Lion TCR Raises $40M in Series B2 Funding, Revolutionizing Solid Tumor Treatment with mRNA-Encoding TCR-T Cell Therapy
The funds raised will be used primarily to support Lion TCR's clinical trials on hepatitis B virus (HBV)-specific TCR T cell therapy, while also facilitati...
June 28, 2023 | News
Brii Biosciences to Sell Equity Interest in Qpex Biopharma and Acquire Global Rights for BRII-693
Company acquires exclusive global rights of the novel lipopeptide BRII-693 for the difficult to treat MDR/XDR gram-negative bacterial infections &nbs...
June 26, 2023 | News
Viva Biotech Announced Strategic Investors with an Investment of Approximately US$ 210 Million
Based on its SBDD strategy, Viva Biotech has achieved remarkable growth in its CRO drug discovery and development business through its continuous effort th...
June 16, 2023 | News
Beaconcure Raises $14 Million Series B to Expand AI-powered Clinical Technology Platform
NewVale Capital leads $14 Million Series B growth round Industry leading executive, Rick Riegel, joins as Chairman of the Board Newly formed Strategic ...
June 14, 2023 | News
Eccogene Raises CNY 180M in Series B Financing for Metabolic Disease Treatments
Eccogene Inc., a clinical-stage biotechnology company developing innovative therapeutic solutions for metabolic diseases, announced a CNY 1...
June 12, 2023 | News
Merck Announces Proteologix as Winner of its North American Advance Biotech Grant
Proteologix to receive in-kind products and services to develop treatments for autoimmune/inflammatory diseases and oncology indications Experts from Me...
June 07, 2023 | News
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
